Goodwin Procter LLP advised Lacerta Therapeutics on the deal. Lacerta Therapeutics announced its collaboration and licensing agreement with UCB. Lacerta Therapeutics is a clinical-stage gene therapy…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
